Survival analysis of breast cancer patients after diagnosis of second primary malignancies, focusing on the second primary hematologic malignancy.

Ann Surg Treat Res · 2023 · PMC10333803 · PMID 37441319

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

The cytotoxic chemotherapy and radiotherapy used to treat primary breast cancer may be significant in the development of SPMs, such as hematologic malignancy or lung cancer [ 2 ].

also in 5,654 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.